A phase II trial of weekly docetaxel in patients with platinum-resistant epithelial ovarian, primary peritoneal serous cancer, or fallopian tube cancer. - Berkenblit,A.; Seiden,M.V.; Matulonis,U.A.; Penson,R.T.; Krasner,C.N.; Roche,M.; Mezzetti,L.; Atkinson,T.; Cannistra,S.A. (Gynecol Oncol, 2004)